معرفی
Aprille Dawn Febre is an Assistant Professor at Loma Linda University School of Medicine, specializing in Pediatric Neonatology. Her research focuses on pharmacological interventions, respiratory support, and metabolic effects in preterm infants.
- Doctor of Medicine (MD), Loma Linda University (2007)
- Bachelor of Science (BS), Southwestern Adventist University (2002)
Her primary research interests include:
- Neonatal pharmacology and drug safety
- Management of bronchopulmonary dysplasia
- ATP metabolism in preterm neonates
- Non-invasive respiratory support technologies
- Clinical trials in neonatal care
Febre's recent publications highlight her work on furosemide safety in preterm infants (2025), oral dextrose for pain management (2020), and respiratory support comparisons (2015). These studies span clinical trials, metabolic effects, and device innovations in neonatal care.
Grants and research projects she has participated in include multicenter trials on caffeine administration (CaLI Trial), antibiotic safety (SCAMP Trial), and delayed cord clamping, funded by institutions like NICHD, NIH, and Duke Clinical Research Institute.
She chairs the Pediatric Evaluation Committee for the Neonatology fellowship at Loma Linda University and serves as a Fellow in the American Academy of Pediatrics.
